Apply Now! 2 Day ESO Webinar To Equip Physicians with Guideline Development Skills
The European Stroke Organisation (ESO) shared an inviting post on X:
”You can still register for the webinar on developing ESO guidelines on 21 and 23 July 2025. Perfect for module working group members and physicians eager to learn about writing guidelines.”
To learn more, follow the link.
The European Stroke Organisation (ESO) is hosting a dedicated webinar designed for members of its module working groups and all physicians eager to enhance their expertise in clinical guideline development.
This educational session introduces participants to the GRADE methodology and the ESO Standard Operating Procedure (SOP) for developing evidence-based guidelines.
By providing structured training, the webinar aims to equip future module working group members with the tools necessary to streamline the process of drafting, evaluating, and publishing clinical guidelines.
Ultimately, this initiative fosters methodological rigor, accelerates the dissemination of best practices, and strengthens the quality of stroke care across Europe.
Do not miss your chance. Apply Now!
Stay informed on opportunities like this with Hemostasis Today .
-
Mar 17, 2026, 18:11Ossama Mansour: Landmark MENA Guidelines for Acute Ischemic Stroke Management
-
Mar 17, 2026, 17:48Andrea Van Beek: Improving DOAC Adherence Saves Lives
-
Mar 17, 2026, 17:43Soumen Bhattacharyya: Microangiopathic Hemolytic Anemia Is Often a Hematologic Clue to Underlying Malignancy
-
Mar 17, 2026, 17:37Peter Bou Dib: New Insights on Factor VIII and the Musculoskeletal System
-
Mar 17, 2026, 17:31Armghan Ans: The 2026 Stroke Guidelines Are Excellent, Now the Hard Part
-
Mar 17, 2026, 17:26Danny Hsu: Navigating a Rebalanced Hemostatic State in Decompensated Cirrhosis
-
Mar 17, 2026, 17:21Matías J Alet on Acute Ischemic Stroke With Low NIHSS at NeuroQuality
-
Mar 17, 2026, 17:16S1PR4 Controls Platelet Fibrinogen Binding and Thrombus Formation – JTH
-
Mar 17, 2026, 15:55Mostafa Faisal Mohammed Saleh: Evidence-Based Recommendations for Hodgkin Lymphoma Management in LMICs